Cargando…

Mechanism of imidazole inhibition of a GH1 β‐glucosidase

Imidazole is largely employed in recombinant protein purification, including GH1 β‐glucosidases, but its effect on the enzyme activity is rarely taken into consideration. Computational docking suggested that imidazole interacts with residues forming the active site of the GH1 β‐glucosidase from Spod...

Descripción completa

Detalles Bibliográficos
Autores principales: Chagas, Rafael S., Otsuka, Felipe A. M., Pineda, Mario A. R., Salinas, Roberto K., Marana, Sandro R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153361/
https://www.ncbi.nlm.nih.gov/pubmed/36906930
http://dx.doi.org/10.1002/2211-5463.13595
_version_ 1785035914331815936
author Chagas, Rafael S.
Otsuka, Felipe A. M.
Pineda, Mario A. R.
Salinas, Roberto K.
Marana, Sandro R.
author_facet Chagas, Rafael S.
Otsuka, Felipe A. M.
Pineda, Mario A. R.
Salinas, Roberto K.
Marana, Sandro R.
author_sort Chagas, Rafael S.
collection PubMed
description Imidazole is largely employed in recombinant protein purification, including GH1 β‐glucosidases, but its effect on the enzyme activity is rarely taken into consideration. Computational docking suggested that imidazole interacts with residues forming the active site of the GH1 β‐glucosidase from Spodoptera frugiperda (Sfβgly). We confirmed this interaction by showing that imidazole reduces the activity of Sfβgly, which does not result from enzyme covalent modification or promotion of transglycosylation reactions. Instead, this inhibition occurs through a partial competitive mechanism. Imidazole binds to the Sfβgly active site, reducing the substrate affinity by about threefold, whereas the rate constant of product formation remains unchanged. The binding of imidazole within the active site was further confirmed by enzyme kinetic experiments in which imidazole and cellobiose competed to inhibit the hydrolysis of p‐nitrophenyl β‐glucoside. Finally, imidazole interaction in the active site was also demonstrated by showing that it hinders access of carbodiimide to the Sfβgly catalytic residues, protecting them from chemical inactivation. In conclusion, imidazole binds in the Sfβgly active site, generating a partial competitive inhibition. Considering that GH1 β‐glucosidases share conserved active sites, this inhibition phenomenon is probably widespread among these enzymes, and this should be taken into account when considering the characterization of their recombinant forms.
format Online
Article
Text
id pubmed-10153361
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101533612023-05-03 Mechanism of imidazole inhibition of a GH1 β‐glucosidase Chagas, Rafael S. Otsuka, Felipe A. M. Pineda, Mario A. R. Salinas, Roberto K. Marana, Sandro R. FEBS Open Bio Research Articles Imidazole is largely employed in recombinant protein purification, including GH1 β‐glucosidases, but its effect on the enzyme activity is rarely taken into consideration. Computational docking suggested that imidazole interacts with residues forming the active site of the GH1 β‐glucosidase from Spodoptera frugiperda (Sfβgly). We confirmed this interaction by showing that imidazole reduces the activity of Sfβgly, which does not result from enzyme covalent modification or promotion of transglycosylation reactions. Instead, this inhibition occurs through a partial competitive mechanism. Imidazole binds to the Sfβgly active site, reducing the substrate affinity by about threefold, whereas the rate constant of product formation remains unchanged. The binding of imidazole within the active site was further confirmed by enzyme kinetic experiments in which imidazole and cellobiose competed to inhibit the hydrolysis of p‐nitrophenyl β‐glucoside. Finally, imidazole interaction in the active site was also demonstrated by showing that it hinders access of carbodiimide to the Sfβgly catalytic residues, protecting them from chemical inactivation. In conclusion, imidazole binds in the Sfβgly active site, generating a partial competitive inhibition. Considering that GH1 β‐glucosidases share conserved active sites, this inhibition phenomenon is probably widespread among these enzymes, and this should be taken into account when considering the characterization of their recombinant forms. John Wiley and Sons Inc. 2023-03-25 /pmc/articles/PMC10153361/ /pubmed/36906930 http://dx.doi.org/10.1002/2211-5463.13595 Text en © 2023 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Chagas, Rafael S.
Otsuka, Felipe A. M.
Pineda, Mario A. R.
Salinas, Roberto K.
Marana, Sandro R.
Mechanism of imidazole inhibition of a GH1 β‐glucosidase
title Mechanism of imidazole inhibition of a GH1 β‐glucosidase
title_full Mechanism of imidazole inhibition of a GH1 β‐glucosidase
title_fullStr Mechanism of imidazole inhibition of a GH1 β‐glucosidase
title_full_unstemmed Mechanism of imidazole inhibition of a GH1 β‐glucosidase
title_short Mechanism of imidazole inhibition of a GH1 β‐glucosidase
title_sort mechanism of imidazole inhibition of a gh1 β‐glucosidase
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153361/
https://www.ncbi.nlm.nih.gov/pubmed/36906930
http://dx.doi.org/10.1002/2211-5463.13595
work_keys_str_mv AT chagasrafaels mechanismofimidazoleinhibitionofagh1bglucosidase
AT otsukafelipeam mechanismofimidazoleinhibitionofagh1bglucosidase
AT pinedamarioar mechanismofimidazoleinhibitionofagh1bglucosidase
AT salinasrobertok mechanismofimidazoleinhibitionofagh1bglucosidase
AT maranasandror mechanismofimidazoleinhibitionofagh1bglucosidase